Skip to content

Released Feb 27, 2020, after the close

10-K filed Feb 28, 2020, 59 days after period end · 0001636422-20-000016

Q4 2019 · 10-K

derived · Computed from the longer spans the company filed.

Revenue$43.50Mderivedno prior Q4 2018 on file+10.3% vs Q3 2019
Net Income-$14.27Mderivedno prior Q4 2018 on fileN/M vs Q3 2019
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$13,672,000—
Operating Cash Flowderived-$13,061,000N/M
Free Cash Flowderived-$13,418,000N/M
Margins · derived
Operating margin-31.4%
Net margin-32.8%

What the release said

The release

Same quarter

MetricQ4 2019derived from reported figuresQ4 2018derived from reported figures
Revenue$43.50M—
Net Income-$14.27M—

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Health Catalyst, Inc. · CIK 1636422 · Engraved from SEC EDGAR